Yu Chieh Su | Cancer Biology | Best Researcher Award

Dr. Yu Chieh Su | Cancer Biology | Best Researcher Award 

Director, Division of Hematology and Oncology | E-DA Hospital | Taiwan

Dr. Yu-Chieh Su’s research focuses on molecular and translational oncology, emphasizing the mechanisms of liver cancer, head and neck cancer, leukemia, and lymphoma. His work investigates tumor biology, resistance pathways, and biomarker discovery to enhance diagnostic accuracy and therapeutic precision. He integrates molecular profiling with immuno-oncology to design targeted therapies that improve patient outcomes. A leader in applying big-data analytics and electronic medical records to oncology, Dr. Su develops predictive models and personalized treatment frameworks using genomic and clinical data integration. His multidisciplinary research extends into artificial intelligence–driven cancer prognosis, genetic biomarker validation, and the study of metabolic influences such as obesity on cancer progression. Through his leadership in national and institutional research initiatives, he has strengthened Taiwan’s position in precision oncology and data-guided cancer care. His contributions have been widely recognized, as reflected in his impressive research metrics, including 4558 total citations, an h-index of 39, and an i10-index of 102 (Google Scholar), with 3,297 citations, an h-index of162, and an i31-index of 69 (Scopus). These achievements demonstrate Dr. Su’s enduring impact on cancer biology, translational research, and the advancement of evidence-based oncology worldwide.

Featured Publications

Su, Y.-C., et al. Prognostic significance of neutrophil-to-lymphocyte ratio in hepatocellular carcinoma. Frontiers in Oncology. — Cited by 128 articles.

Su, Y.-C., et al. Integrative genomic analysis reveals biomarkers for head and neck cancer. BMC Cancer. — Cited by 94 articles.

Su, Y.-C., et al. Clinical outcomes of hematologic malignancies under novel immunotherapy protocols. Medicine (Baltimore). — Cited by 87 articles.

Mahnoosh Mokhtarinejad | Cancer Biology | Best Researcher Award

Mrs . Mahnoosh Mokhtarinejad | Cancer Biology | Best Researcher Award 

Laboratory Expert , Faculty of Pharmacy and Pharmaceutical of sciences, Hormozgan University of Medical sciences, Iran .

Mahnoosh Mokhtarinejad is a researcher in genetics, with expertise in cancer biology, gene expression, and bioinformatics. Based in Iran, she holds advanced degrees in Human Genetics and Cellular and Molecular Biology. She currently works as a laboratory expert and technician at the Faculty of Pharmacy and Pharmaceutical Sciences, Hormozgan University of Medical Sciences, Iran. Her research focuses on the molecular aspects of cancer, particularly head and neck squamous cell carcinoma (HNSCC).

Profile

Scopus

Education

🎓 Mahnoosh earned her Master’s degree in Human Genetics from Tehran University of Medical Science (2016-2018), where her thesis explored the expression of specific lncRNAs and mRNAs in HNSCC. Prior to this, she completed a Bachelor’s degree in Cellular and Molecular Biology-Genetics from Shahid Chamran University of Ahvaz (2011-2015), with coursework covering biochemistry, genetics, and oncology.

Experience

🧪 Mahnoosh has worked as a Laboratory Expert and Technician at Hormozgan University of Medical Sciences since 2021, where she conducts research on gene expression in cancer cells. She also serves as a teaching assistant, guiding pharmacy students through laboratory experiments. She previously worked as a Medical Sales Representative for Niksan Salamat Behbood Company in 2020.

Research Interests

🔬 Mahnoosh’s research interests revolve around cancer biology, gene expression regulation, epigenetics, pharmacogenetics, and bioinformatics. She is particularly focused on the molecular mechanisms underlying cancers like HNSCC, exploring the role of long non-coding RNAs (lncRNAs) and tumor suppressor genes.

Awards

🏆 Mahnoosh has been actively engaged in academic and professional circles, contributing to her field through participation in congresses such as the IRHRC Annual Meeting on Reproductive and Infertility Updates.

Publications

📚 2024
Mokhtarinejad, M., Pirhoushiaran, M., Heidarzadehpilehrood, R., Hesami, S., Azmoudeh-Ardalan, F., Shakoori Farahani, A. Upregulated long non-coding RNAs TMPO-AS1, DDX11-AS1, and POLE gene expression predict poor prognosis in head and neck squamous cell carcinoma (HNSCC). Gene Reports, cited by 6 articles.

📚 2020
Mehrabi, S., Pirhoushiaran, M., Eshaghkhani, Y., Teimourzadeh Baboli, A., Mahmoudi, A., Zarifian Yeganeh, R., Abdollahzadeh, R., Sadeghi Rad, H., Mokhtarinejad, M., Shakoori Farahani, A. Molecular Analysis of EGFR and PIK3CA Genetic Mutations in Iranian Patients with Head and Neck Squamous Cell Carcinoma. International Journal of Pharmaceutical and Phytopharmacological Research, cited by 12 articles.

📚 2023
Jamil, M., Mohammadi-Bardbori, A., Safa, O., Nikpoor, A.R., Bakhtari, A., Mokhtarinejad, M., Naybandi Zadeh, S., Shadboorestan, A., Omidi, M. Arsenic trioxide-induced cytotoxicity in A549 cells: The role of necroptosis. Drug Research, cited by 4 articles.

Conclusion

Mahnoosh Mokhtarinejad is a strong candidate for the Best Researcher Award, with a rich background in cancer genetics, particularly focusing on molecular aspects of head and neck squamous cell carcinoma. Her publications in reputable journals, technical expertise, and role as a laboratory expert reflect her dedication to scientific advancement. However, expanding her leadership in large-scale research projects and enhancing her international exposure could further elevate her profile for this award. Overall, her work in cancer genetics holds significant promise and aligns well with the criteria for recognition in research excellence.